Roche, in collaboration with KlinRisk, Inc, has received CE-mark for the first AI-based risk stratification tool for ...

The tool assesses progressive decline in kidney function and will be launched as part of Roche's new chronic kidney disease algorithm panel.

Living kidney donation necessitates rigorous pre‐donation evaluation to ensure donor safety and optimise postoperative outcomes. A critical component in this process is the accurate assessment of ...

Cystatin C is an emerging biomarker that enhances kidney function assessment accuracy, particularly in hospitalized patients ...

Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function More than 800 million people have Chronic ...

NEW YORK - INNOVATE Corp. (NYSE: VATE), whose stock has surged over 130% in the past six months despite a recent 21% weekly decline according to InvestingPro data, announced the approval by the ...

Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function The transdermal GFR (tGFR) methodology has ...

HOW TO TAKE THE POST-TEST: To obtain CME credit, please click here after reading the article to take the post-test on myCME.com. Clinical assessment of kidney function is central to the practice of ...

Boditech Med and SphingoTec announce the launch of the AFIAS sphingotest® penKid® assay, a diagnostic tool designed to aid in kidney function assessment for critically ill patients. The ...

Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function. The transdermal GFR (tGFR) methodology has ...